AnaptysBio Inc expected to post a loss of $1.05 a share - Earnings Preview

AnaptysBio

28/04/2023 12:32

* AnaptysBio Inc  ANAB.OQ   ANAB.O  is expected to show a
rise in
quarterly revenue when it reports  results on May 2
(estimated). 
    * The San Diego California-based  company is expected to
report  a
268.6% increase in revenue to $3.575 million from $970 thousand
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for AnaptysBio Inc is
for a
loss of $1.05 per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months. ​
    * Wall Street's median 12-month price target for AnaptysBio
Inc is
$28​, above​ its last closing price of $20.84. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.96       -0.96      -0.93     Beat    2.8
 Sep. 30 2022  -0.65       -0.72      -1.18     Missed  -63.1
 Jun. 30 2022  -0.89       -1.02      -1.15     Missed  -12.6​
 Mar. 31 2022  -1.02       -0.99      -1.31     Missed  -31.7
 ​​Dec.        5.54        2.57       -1.13     Missed  -143.9
 31 2021                                                
 Sep. 30 2021  -0.93       -0.91      -0.24     Beat    73.6​
 Jun. 30 2021  -0.11       -0.11      -0.02     Beat    81.3
 Mar. 31 2021  -0.77       -0.69      -0.66     Beat    4.1
 This summary was machine generated April 28 at 11:32 GMT.  All
figures in US dollars  unless otherwise stated